menu
    • menu

    Company profile for Sequana Medical

    NEW Drugs in Dev: 4
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a commercial stage medical device company developing the alfapump® platform for the treatment of fluid overload in liver disease, malignant ascites and heart failure where diuretics are no longer effective. The alfapump®, is a fully implantable, programmable, wirelessly-charged, battery-powered system that is CE-marked for the treatment of refractory ascites due to liver cirrhosis and malignant ascites. Over 900 a...
    We are a commercial stage medical device company developing the alfapump® platform for the treatment of fluid overload in liver disease, malignant ascites and heart failure where diuretics are no longer effective. The alfapump®, is a fully implantable, programmable, wirelessly-charged, battery-powered system that is CE-marked for the treatment of refractory ascites due to liver cirrhosis and malignant ascites. Over 900 alfapump® systems have been implanted. The alfapump® has been endorsed by key independent third parties in Europe and has received Breakthrough Device status from the US FDA.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Sequana MedicalBelgium Flag
    Country
    Country
    Belgium
    Address
    Address
    Technologiepark 122 9052, Zwijnaarde
    Telephone
    Telephone
    +32 9 292 8065
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.sequanamedical.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/2243173/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/sequanamed

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Firm Halts Trading for AGM Review
    Firm Halts Trading for AGM Review

    28 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/28/3283148/0/en/financial-and-strategic-review-annual-general-meeting-and-trading-halt.html

    GLOBENEWSWIRE
    28 Apr 2026
    Share Share
    Sequana Medical Reveals Increased Share Capital & Share Count
    Sequana Medical Reveals Increased Share Capital & Share Count

    27 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7211420

    FIRSTWORD PHARMA
    27 Apr 2026
    Share Share
    Company Issues New Shares and Share Subscription Notice to GEM
    Company Issues New Shares and Share Subscription Notice to GEM

    26 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/26/3263359/0/en/NEW-SHARE-CAPITAL-AMOUNT-AND-NEW-NUMBER-OF-SHARES-ISSUANCE-OF-A-NEW-SUBSCRIPTION-REQUEST-NOTICE-UNDER-THE-SHARE-SUBSCRIPTION-FACILITY-AGREEMENT-WITH-GEM.html

    GLOBENEWSWIRE
    26 Mar 2026
    Share Share
    Company Issues New Shares Under Share Subscription Facility
    Company Issues New Shares Under Share Subscription Facility

    05 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/05/3249842/0/en/NEW-SHARE-CAPITAL-AMOUNT-AND-NEW-NUMBER-OF-SHARES-ISSUANCE-OF-A-NEW-SUBSCRIPTION-REQUEST-NOTICE-UNDER-THE-SHARE-SUBSCRIPTION-FACILITY-AGREEMENT-WITH-GEM.html

    GLOBENEWSWIRE
    05 Mar 2026
    Share Share
    Sequana Announces the Issuance of Subscription Request Notice
    Sequana Announces the Issuance of Subscription Request Notice

    02 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/02/3230483/0/en/SEQUANA-MEDICAL-ANNOUNCES-THE-ISSUANCE-OF-A-SUBSCRIPTION-REQUEST-NOTICE-UNDER-THE-SHARE-SUBSCRIPTION-FACILITY-AGREEMENT-WITH-GEM.html

    GLOBENEWSWIRE
    02 Feb 2026
    Share Share
    Sequana Medical Reveals Updated Share Capital and Share Count
    Sequana Medical Reveals Updated Share Capital and Share Count

    27 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/27/3226071/0/en/SEQUANA-MEDICAL-ANNOUNCES-NEW-SHARE-CAPITAL-AMOUNT-AND-NEW-NUMBER-OF-SHARES.html

    GLOBENEWSWIRE
    27 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search